
medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 4, 2024
ABSTRACT Estimating global lives and life-years saved is important to put into perspective the benefits of COVID-19 vaccination. Prior studies have focused mainly on pre-Omicron period or only specific regions, lack crucial life-year calculations, often depend strong modeling assumptions with unaccounted uncertainty. We aimed calculate by vaccination worldwide from onset campaigns until October 2024. considered different strata according age; community-dwelling long-term care residence status; Omicron periods; before after a SARS-CoV-2 infection. In main analysis, 2.533 million deaths were averted. Eighty-two percent among people vaccinated any infection, 57% in period, 90% pertained 60 years above. Sensitivity analyses suggested 1.4 4.0 saved. Some sensitivity showed preponderance benefit during period. estimated 14.8 (sensitivity range, 7.4-23.6 life-years). Most (76%) over old, but residents contributed 2% total. Children adolescents (0.01% 0.1% saved) young adults 20-29 old (0.07% 0.3% had very small contributions total benefit. Based number assumptions, these estimates are substantially more conservative than previous calculations focusing mostly first year vaccination, they still undeniably demonstrate major overall 2020-2024. The vast majority was secured for portion elderly minority population.
Language: Английский